GoHealth Income Tax Expense vs Research Development Analysis
GOCO Stock | USD 8.59 0.42 4.66% |
GoHealth financial indicator trend analysis is much more than just examining GoHealth latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GoHealth is a good investment. Please check the relationship between GoHealth Income Tax Expense and its Research Development accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.
Income Tax Expense vs Research Development
Income Tax Expense vs Research Development Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GoHealth Income Tax Expense account and Research Development. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between GoHealth's Income Tax Expense and Research Development is -0.14. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Research Development in the same time period over historical financial statements of GoHealth, assuming nothing else is changed. The correlation between historical values of GoHealth's Income Tax Expense and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of GoHealth are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Income Tax Expense i.e., GoHealth's Income Tax Expense and Research Development go up and down completely randomly.
Correlation Coefficient | -0.14 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Income Tax Expense
Research Development
Most indicators from GoHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GoHealth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.At this time, GoHealth's Selling General Administrative is very stable compared to the past year. As of the 14th of May 2024, Sales General And Administrative To Revenue is likely to grow to 0.20, while Tax Provision is likely to drop about 63.6 K.
2023 | 2024 (projected) | Depreciation And Amortization | 105.7M | 84.0M | Interest Income | 9.4M | 9.9M |
GoHealth fundamental ratios Correlations
Click cells to compare fundamentals
GoHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
GoHealth fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.6B | 2.1B | 2.1B | 1.7B | 1.5B | 1.7B | |
Short Long Term Debt Total | 291.7M | 400.6M | 696.3M | 557.4M | 592.4M | 466.3M | |
Other Current Liab | 25.3M | 35.3M | 61.1M | 63.4M | 85.6M | 52.0M | |
Total Current Liabilities | 113.1M | 127.4M | 217.1M | 265.5M | 370.0M | 209.2M | |
Total Stockholder Equity | 860.1M | 378.8M | 353.1M | 318.1M | 231.0M | 358.3M | |
Other Liab | 340.9M | 185.8M | 274.4M | 259.0M | 233.1M | 214.6M | |
Net Tangible Assets | (309.2M) | (694.9M) | (241.6M) | (182.6M) | (209.9M) | (220.4M) | |
Property Plant And Equipment Net | 6.3M | 17.4M | 47.7M | 46.8M | 48.8M | 32.8M | |
Current Deferred Revenue | 15.2M | 736K | 536K | 50.6M | 67.2M | 70.6M | |
Net Debt | 279.4M | 256.3M | 611.9M | 541.0M | 501.5M | 402.4M | |
Retained Earnings | (312.6M) | (18.8M) | (208.3M) | (357.0M) | (420.3M) | (399.3M) | |
Accounts Payable | 69.6M | 87.2M | 144.0M | 137.2M | 136.4M | 110.6M | |
Cash | 12.3M | 144.2M | 84.4M | 16.5M | 90.8M | 63.9M | |
Non Current Assets Total | 1.5B | 1.7B | 1.6B | 1.2B | 1.0B | 1.3B | |
Non Currrent Assets Other | 282.9M | 624.3M | 997.5M | 697.4M | 577.7M | 597.1M | |
Other Assets | 282.9M | 624.3M | 997.5M | 697.4M | 802.0M | 589.4M | |
Cash And Short Term Investments | 12.3M | 144.2M | 84.4M | 16.5M | 90.8M | 63.9M | |
Net Receivables | 125.5M | 218.4M | 285.9M | 340.5M | 911.9M | 957.5M | |
Common Stock Shares Outstanding | 5.6M | 5.6M | 7.1M | 8.4M | 9.3M | 7.6M | |
Long Term Debt Total | 288.7M | 396.4M | 665.1M | 504.8M | 580.5M | 408.1M | |
Liabilities And Stockholders Equity | 1.6B | 2.1B | 2.1B | 1.7B | 1.5B | 1.7B | |
Non Current Liabilities Total | 629.1M | 582.3M | 959.3M | 802.1M | 674.6M | 720.3M | |
Capital Lease Obligations | 421K | 396.4M | 25.9M | 47.3M | 45.3M | 68.7M | |
Other Current Assets | 6.0M | 29.2M | 58.7M | 57.6M | (1.0B) | (952.6M) | |
Other Stockholder Equity | 312.6M | 397.5M | 561.4M | 625.9M | 602.1M | 461.9M | |
Total Liab | 742.2M | 709.6M | 1.2B | 1.1B | 1.1B | 938.5M | |
Net Invested Capital | 603.8M | 781.0M | 1.0B | 778.8M | 728.7M | 684.6M | |
Total Current Assets | 143.8M | 391.8M | 429.0M | 414.6M | 476.4M | 350.1M | |
Accumulated Other Comprehensive Income | (17K) | (18.8M) | (208.4M) | (144K) | (127K) | (133.4K) | |
Non Current Liabilities Other | 242.7M | 3.3M | 294.2M | 297.3M | 9.1M | 8.6M | |
Net Working Capital | 30.7M | 264.5M | 211.9M | 149.1M | 106.4M | 140.9M | |
Short Term Debt | 3M | 4.2M | 11.4M | 14.2M | 80.8M | 84.8M | |
Property Plant Equipment | 6.3M | 17.4M | 47.7M | 46.8M | 53.8M | 28.6M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GoHealth in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GoHealth's short interest history, or implied volatility extrapolated from GoHealth options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.Note that the GoHealth information on this page should be used as a complementary analysis to other GoHealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for GoHealth Stock analysis
When running GoHealth's price analysis, check to measure GoHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GoHealth is operating at the current time. Most of GoHealth's value examination focuses on studying past and present price action to predict the probability of GoHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GoHealth's price. Additionally, you may evaluate how the addition of GoHealth to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is GoHealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.241 | Earnings Share (7.19) | Revenue Per Share 77.759 | Quarterly Revenue Growth 0.013 | Return On Assets (0.03) |
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.